Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate + S-ketamine induction in elderly total knee arthroplasty
ChiCTR2000040682Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Hemodynamics and Catecholamine levels. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2000040682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040682.